Journal
CLINICAL INFECTIOUS DISEASES
Volume 43, Issue 3, Pages 312-314Publisher
OXFORD UNIV PRESS INC
DOI: 10.1086/505493
Keywords
-
Categories
Ask authors/readers for more resources
The association between rotavirus serotypes and severity is not well established. Analysis of a clinical trial conducted in Latin America points at more-severe disease associated with serotype G9. Thus, demonstration of efficacy against G9 will be an important asset of any rotavirus vaccine to be introduced into a Latin American country or any country where G9 has been shown to be prevalent.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available